Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Michael Whitley, 43, has a can-do attitude that helps him navigate a complex path through metastatic kidney cancer.
Researchers build a functional taxonomy of the tumor suppression genes involved in lung cancer.
I hoped the first sign of “growth” in one of my tumors was a measurement error, but the PET scan told me that I’m not fooling anyone.
A new technique called CopyKAT can identify genetic abnormalities linked to cancer in a single cell.
CU Cancer Center’s Joaquin Espinosa, PhD, and his team investigated hypoxia-inducible factors in tumor growth and suppression.
David de Wilde works to spread awareness of testicular cancer in Belgium.
An inside look at five research developments that have the potential to transform the treatment of cancer
I’ve been extremely fortunate to go more than five years longer than the average time on the drug I’m taking. But now things have changed.
New guidelines for treating Wilms Tumor share information for earlier, safer diagnosis and treatment in an effort to reduce disparities.
New research shows that gene activity could be used to predict tumors most likely to benefit from “genotoxic” therapies
Obesity may render T cells around tumors less powerful by causing them to alter how they generate and use energy, a new study suggests.
In the midst of his testicular cancer journey, Anthony Mastrogiulio found his cancer family.
Genomic testing can help customize treatment to target tumors.
Damon Runyon researchers are making an impact through understanding the biology and developing novel treatments.
Tumors with large numbers of genetic mutations may be especially susceptible to treatment with immunotherapy.
BO-112 helped make tumor cells more vulnerable to immunotherapy, offering a possible treatment route for hard-to-treat cancers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.